1. Home
  2. OCUL vs BHE Comparison

OCUL vs BHE Comparison

Compare OCUL & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • BHE
  • Stock Information
  • Founded
  • OCUL 2006
  • BHE 1979
  • Country
  • OCUL United States
  • BHE United States
  • Employees
  • OCUL N/A
  • BHE N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • BHE Electrical Products
  • Sector
  • OCUL Health Care
  • BHE Technology
  • Exchange
  • OCUL Nasdaq
  • BHE Nasdaq
  • Market Cap
  • OCUL 1.4B
  • BHE 1.3B
  • IPO Year
  • OCUL 2014
  • BHE 1990
  • Fundamental
  • Price
  • OCUL $11.03
  • BHE $39.98
  • Analyst Decision
  • OCUL Strong Buy
  • BHE Strong Buy
  • Analyst Count
  • OCUL 7
  • BHE 2
  • Target Price
  • OCUL $17.33
  • BHE $47.00
  • AVG Volume (30 Days)
  • OCUL 2.4M
  • BHE 279.9K
  • Earning Date
  • OCUL 08-06-2025
  • BHE 07-29-2025
  • Dividend Yield
  • OCUL N/A
  • BHE 1.71%
  • EPS Growth
  • OCUL N/A
  • BHE N/A
  • EPS
  • OCUL N/A
  • BHE 1.44
  • Revenue
  • OCUL $59,647,000.00
  • BHE $2,612,294,000.00
  • Revenue This Year
  • OCUL N/A
  • BHE $0.52
  • Revenue Next Year
  • OCUL $20.05
  • BHE $8.50
  • P/E Ratio
  • OCUL N/A
  • BHE $27.64
  • Revenue Growth
  • OCUL N/A
  • BHE N/A
  • 52 Week Low
  • OCUL $5.79
  • BHE $30.73
  • 52 Week High
  • OCUL $11.78
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 76.75
  • BHE 59.03
  • Support Level
  • OCUL $9.36
  • BHE $39.56
  • Resistance Level
  • OCUL $9.75
  • BHE $40.69
  • Average True Range (ATR)
  • OCUL 0.54
  • BHE 0.82
  • MACD
  • OCUL 0.18
  • BHE 0.07
  • Stochastic Oscillator
  • OCUL 91.46
  • BHE 78.22

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: